SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Genesis Solar Corp – ‘10-Q’ for 12/31/08

On:  Tuesday, 2/17/09, at 5:06pm ET   ·   For:  12/31/08   ·   Accession #:  1000096-9-66   ·   File #:  2-87052-D

Previous ‘10-Q’:  ‘10-Q’ on 11/13/08 for 9/30/08   ·   Next:  ‘10-Q’ on 8/14/09 for 6/30/09   ·   Latest:  ‘10-Q’ on 8/15/11 for 6/30/11

  in    Show  and    Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/17/09  Genesis Solar Corp                10-Q       12/31/08    3:186K                                   Mitchell Fi… Printing/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    173K 
 2: EX-31       Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 3: EX-32       Certification per Sarbanes-Oxley Act (Section 906)  HTML      6K 


10-Q   —   Quarterly Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  cogenco123108.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing  

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[   X   ]          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2008

OR

[     ]          TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 2 - 87052 - D

Cogenco International, Inc.
(Exact name of Registrant as specified in its charter)

Colorado    84-0914754 
(State or other jurisdiction of    (IRS Employer Identification 
incorporation or organization)    Number) 

Suite 1840, 6400 South Fiddler’s Green Circle, Greenwood Village, CO 80111 
(Address of principal executive offices and Zip Code) 
 
(303) 758-1357 
(Registrant's telephone number) 
 


Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  Yes   [ X ]     No     [   ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes    [ X ]      No [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company:

Large accelerated filer         ¨          Accelerated filer         ¨    Non-accelerated filer         ¨          Smaller reporting company        R

The number of shares outstanding of the issuer's classes of common stock, as of February 12, 2009 was 1,233,000 shares, $.01 par value.


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)

INDEX

PART I. FINANCIAL INFORMATION 
    
         Item 1:    Financial Statements 
    
                   Balance Sheet – March 31, 2008 and December 31, 2008 (unaudited) 
    
                   Statement of Operations – For the Three Months Ended December 31, 2007 and 2008 (unaudited) 
                   
                   Statement of Operations – For the Nine Months Ended December 31, 2007 
                   and 2008 and Cumulative Amounts from Inception of the Development 
                   Stage (October 1, 2008) through December 31, 2008 (unaudited) 
    
                   Statement of Stockholders' Equity - For the Nine Months Ended December 31, 2008 (unaudited)  
     
                   Statement of Cash Flows - For the Nine Months Ended December 31, 2007 
                   and 2008 and Cumulative Amounts from Inception of the Development 
                   Stage (October 1, 2008) through December 31, 2008 (unaudited) 
    
                   Notes to Unaudited Financial Statements 
    
         Item 2:    Management’s Discussion and Analysis of Financial Condition and Results of Operation 
    
         Item 3:    Quantitative and Qualitative Disclosure About Market Risk 
    
         Item 4T:    Controls and Procedures 
    
PART II. OTHER INFORMATION 
    
         Item 1:    Legal Proceedings 
    
         Item 1A:    Risk Factors 
    
         Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds 
    
         Item 3.    Defaults upon senior securities. 
    
         Item 4.    Submission of matters to a vote of security holders. 
    
         Item 5.    Other information. 
    
         Item 6.    Exhibits 
    
         Signatures     
     
         Certification pursuant to Securities Exchange Act of 1934 and 
         Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
BALANCE SHEET
March 31, 2008 and December 31, 2008
 (Audited)                 (Unaudited)

ASSETS
      March       December  
Current assets:                 
   Cash, in interest bearing accounts    $ 1,386     $ 49,709  
   Certificate of deposit (Note 3)      84,727       -  
   Note receivable - related party - current portion (Note 3)      85,803       112,649  
   Interest receivable - related party (Note 3)      -       3,139  
   Prepaid expense      5,515       -  
 
       Total current assets      177,431       165,497  
 
Computer equipment, at cost, net of accumulated                 
   depreciation of $1,930 (March) and $2,517 (December)      1,570       983  
Note receivable - related party - net of current portion (Note 3)      164,197       95,599  
 
 
Total assets    $ 343,198     $ 262,079  
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:                 
   Accounts payable    $ 8,473     $ 2,281  
   Accounts payable - related party      10,986       7,366  
   Accrued salary - officer      241,750       241,750  
 
       Total current liabilities      261,209       251,397  
 
Stockholders' equity:                 
   Preferred stock, $.01 par value; 10,000,000 shares                 
       authorized, no shares issued and outstanding      -       -  
   Common stock, $.01 par value; 50,000,000 shares                 
       authorized, 1,233,000 (March) and (December)                 
       shares issued and outstanding      12,330       12,330  
   Additional paid-in capital      6,150,558       6,150,558  
   Accumulated deficit (including $16,723 deficit                 
       accumulated during the development stage at                 
       December 31, 2008) (Note 1)      (6,080,899 )      (6,152,206 ) 
 
   Total stockholders' equity      81,989       10,682  
 
   Total liabilities and stockholders' equity    $ 343,198     $ 262,079  

See accompanying notes.
2


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
STATEMENT OF OPERATIONS
For the Three Months Ended December 31, 2007 and 2008
(Unaudited)

      2007       2008  
Costs and expenses:                 
   Salary - officer    $ 37,500     $ -  
   Legal fees      2,867       4,126  
   Consulting and travel expenses -                 
       related party      -       940  
   General and administration      5,934       6,978  
   Rent and storage expenses      16,555       16,050  
   Depreciation      196       195  
       Total costs and expenses      63,052       28,289  
Other income                 
   Rental income      8,355       8,425  
   Interest income      905       3,141  
       Total other income      9,260       11,566  
             Net loss (Note 2)    $ (53,792 )    $ (16,723 ) 
Basic and diluted loss per common share    $ (0.02 )    $ (0.01 ) 
Weighted average number of common                 
   shares outstanding      2,656,256       1,233,000  

See accompanying notes.
3


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
STATEMENT OF OPERATIONS
For the Nine Months Ended December 31, 2007 and 2008 and Cumulative Amounts
from Inception of the Development Stage (October 1, 2008) Through December 31, 2008
(Unaudited)

                      Cumulative  
                      amounts from  
      2007       2008       Inception  
Costs and expenses:                         
   Salary - officer    $ 112,500     $ -     $ -  
   Legal fees - related party (Note 3)      3,000       -       -  
   Legal fees      52,302       14,167       4,126  
   Consulting and travel expenses -                         
       related party      8,687       18,290       940  
   General and administration      41,297       26,578       6,978  
   Rent and storage expenses      49,478       48,590       16,050  
   Depreciation      587       587       195  
       Total costs and expenses      267,851       108,212       28,289  
Other income                         
   Rental income      24,670       24,805       8,425  
   Interest income      2,827       12,100       3,141  
       Total other income      27,497       36,905       11,566  
             Net loss (Note 2)    $  (240,354 )    $  (71,307 )    $  (16,723 ) 
Basic and diluted loss per common share    $  (0.09 )    $  (0.06 )    $  (0.01 ) 
Weighted average number of common                         
   shares outstanding      2,656,256       1,233,000       1,233,000  

See accompanying notes.
 4


COGENCO INTERNATIONAL, INC.
 (A Development Stage Company)
STATEMENT OF STOCKHOLDERS' EQUITY
For the Nine Months Ended December 31, 2008
(Unaudited) 
             
 
                Additional              Total  
    Common stock     paid-in      Accumulated       stockholders'  
         Shares      Amount       capital        deficit       equity  
 
 
Balance at March 31, 2008         1,233,000    $ 12,330    $    6,150,558    $ (6,080,899 )    $ 81,989  
 
Net loss for the nine months                                 
     ended December 31, 2008                           -      -    -      (71,307 )      (71,307 ) 
Balance at December 31, 2008         1,233,000    $ 12,330    $    6,150,558    $ (6,152,206 )    $ 10,682  

See accompanying notes.
5


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
STATEMENT OF CASH FLOWS
For the Nine Months Ended December 31, 2007 and 2008 and Cumulative Amounts
from Inception of the Development Stage (October 1, 2008) through December 31, 2008
(Unaudited)

 

      Nine months Ended       Cumulative  
      December 31,       amounts from  
      2007       2008       Inception  
Cash flows from operating activities:                         
   Net loss    $ (240,354 )    $ (71,307 )    $ (16,723 ) 
   Adjustment to reconcile net loss to net                         
         cash used in operating activities:                         
             Depreciation expense      587       587       195  
             Change in interest receivable and prepaid                         
                 expense      (8,025 )      2,376       16,375  
             Change in accounts payable and                         
                 accrued salary - officer      96,935       (9,812 )      (3,596 ) 
             Net cash used in operations      (150,857 )      (78,156 )      (3,749 ) 
Cash flows from investing activities:                         
   Payment on note receivable      -       41,752       21,536  
   Purchase of securities      (480,000 )      -       -  
   Sale of securities      600,000       -       -  
   Purchase certificate of deposit      (2,661 )      (709 )      -  
   Redeem certificate of deposit      -       85,436       -  
             Net cash provided by investing                         
                 activities      117,339       126,479       21,536  
Net increase (decrease) in cash      (33,518 )      48,323       17,787  
Cash and cash equivalents at                         
   beginning of year      41,744       1,386       31,922  
Cash and cash equivalents at                         
   end of period    $ 8,226     $ 49,709     $ 49,709  

See accompanying notes.
 6


 

COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
NOTES TO UNAUDITED FINANCIAL STATEMENTS
December 31, 2008

1.      Basis of presentation
 
  Effective October 1, 2008, the Company has decided to begin a search for a new business opportunity as a merger with DMI BioSciences, Inc. (“DMI”) appears unlikely. The Company is therefore entering a new development stage as more fully defined in SFAS No. 7.
 
  The accompanying financial statements have been prepared by the Company, without audit. In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting of only normal recurring accruals) necessary for a fair presentation of the financial position as of March 31, 2008 and December 31, 2008, and the results of operations and cash flows for the periods ended December 31, 2007 and 2008. The financial statements have been prepared on a going concern basis which contemplates the realization of assets and liquidation of liabilities in the ordinary course of business. As shown in the accompanying financial statements, the Company has incurred significant losses from inception to date and does not have sufficient funds on hand to continue to fund operations. As a development stage company, the Company continues to rely on infusions of equity capital to fund operations. As a result, substantial doubt exists about the Company’s ability to continue to fund future operations using its existing resources. The Company continues to seek equity investments of which there can be no assurance.
 
2.      Income taxes
 
  No provision for income taxes is required at March 31, 2008 and December 31, 2008 because, in management’s opinion and based on historical performance the effective tax rate for the years will be zero.
 
  As of March 31, 2008 and December 31, 2008, total deferred tax assets and valuation allowance are as follows:
 
            March 31,       December 31,  
            2008       2008  
      Deferred tax assets resulting from:                 
      Loss carryforward    $  298,100     $  324,700  
      Future deduction for accrued salaries      90,200       90,200  
      Valuation allowance      (388,300 )      (414,900 ) 
          $  -     $  -  
 
3 .    Related party transactions                 

For the nine months ended December 31, 2007, and 2008, and from inception of the development stage, the Company incurred legal costs of $3,000, $0, and $0, respectively, from one law firm in which a principal of the law firm is both a former director of the Company and a father of the Company’s president.

7


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
NOTES TO UNAUDITED FINANCIAL STATEMENTS
December 31, 2008

3.      Related party transactions (continued)
 
  In November 2004 we entered into an employment contract with David Brenman (the Company’s president) which became effective on or about September 30, 2005, when we paid DMI $3,250,000 for participation in the co-development agreement. The employment agreement was approved by our board of directors, including David Brenman’s father and brother-in-law. The material terms of David Brenman’s employment agreement are described in our annual report on Form 10-KSB for the year ended March 31, 2008. We paid Mr. Brenman his salary as due under the employment agreement through August 15, 2006, but we have been unable to make payments to him as required under his employment agreement beginning August 31, 2006, except for $2,000 paid June 2007. Mr. Brenman has orally agreed to defer (without interest) collection of any other amounts due under his employment agreement until such time as Cogenco is adequately financed. Further, on March 31, 2008 Mr. Brenman orally agreed to suspend the accrual of his salary until Cogenco is adequately financed. Mr. Brenman was provided with the $2,000 payment in salary to prevent our payroll company from discontinuing their services due to lack of use.
 
  During our 2006 and 2007 fiscal years, Cogenco raised $3,900,000 from offshore private placements using a Liechtenstein-based fund manager, MJM as a finder. MJM and Cogenco entered into a Finder’s Agreement containing the following terms: Cogenco agrees to engage MJM on a non- exclusive basis; Cogenco shall pay MJM a finder’s fee of 7 ˝% of the funds raised from MJM’s European clients; each party shall be entitled to indemnification under certain circumstances; and Cogenco shall reimburse MJM for related expenses. As a result, Cogenco paid MJM a finder’s fee of $292,500. The fund manager paid one-third of the finder’s fee to David W. Brenman president of Cogenco, in accordance with an oral agreement between them. Pursuant to that oral agreement, Mr. Brenman will be entitled to receive one-fifth of the fund manager’s profits from making the investment in Cogenco. Through January 1, 2007, MJM was owned and operated by Harold Janssen, who, through MJM and Genesis Investment Funds Limited, is a principal shareholder of Cogenco and has had prior personal relationships with Mr. Brenman.
 
  In October 2005, Cogenco entered into an office lease with an unaffiliated party for approximately 3,210 square feet at the rate of $5,350 per month over its term of 38 months. A certificate of deposit was pledged as collateral on a line of credit securing the lease. On May 28, 2008 the certificate of deposit then in the amount of $85,436 was redeemed. Cash proceeds of $37,560 from the redemption were used to prepay the office rent through December 2008 and release Cogenco from the $70,000 letter of credit securing the lease. With the consent of the unaffiliated landlord, Cogenco has agreed to sublease a portion of the space (approximately 1,605 square feet) to another company (Micro-Imaging Solutions, LLC. or “MIS”) for $2,675 per month (Cogenco’s cost). The income from this sublease was $24,670 and $24,805 for the nine months ended December 31, 2007 and 2008. MIS is responsible for its pro-rata share of other expenses incurred under the lease. The sublease is on a month-to-month basis, and Cogenco expects that MIS’s use of the office space will continue during the remaining term of Cogenco’s lease, depending on MIS’s financial capabilities. An affiliate of David Brenman has a significant equity interest in MIS. The lease and sublease was approved by the remaining members of the Cogenco board of directors, including Mr. David Brenman’s father and his brother-in-law.
 
     
 

8

 


COGENCO INTERNATIONAL, INC.
(A Development Stage Company)
NOTES TO UNAUDITED FINANCIAL STATEMENTS
December 31, 2008

3.      Related party transactions (continued) 
 
  Since August 2004 Cogenco has entered into agreements creating various relationships with DMI. Pursuant to one of the agreements Cogenco paid DMI $3,250,000, however due to a lack of funding did not make any of the payments contemplated by a separate agreement. Because Cogenco was unable to provide DMI the funding contemplated by the agreements between the parties, on June 22, 2007 Cogenco’s $3,250,000 investment in DMI was converted into 1,000,000 shares of DMI stock. Cogenco also entered into a series of stock purchase agreements with DMI and purchased a total of 673,256 shares of DMI from March 31, 2007 through the quarter ended December 31, 2007. As a result of these transactions on December 31, 2007 Cogenco owned 1,673,256 shares of DMI stock.
 
  On March 7, 2008 Cogenco sold all of its shares of DMI to Genesis Biotechnology Fund Limited (“Genesis Biotech”) and Genesis Capital Management Limited (“Genesis Management”). Cogenco sold 1,423,256 shares of DMI to Genesis Biotech in consideration for Genesis Biotech surrendering 1,423,256 shares of Cogenco common stock and sold 250,000 shares to Genesis Management in consideration for a promissory note in the face amount of $250,000. This note carries 6% interest and provides that Genesis Management will pay Cogenco $25,000 per quarter. The first payment was made by Genesis Management on June 26, 2008. The final payment is due on December 31, 2010. Total principal and interest payments will total $275,000. The payment of $25,000 due for the quarter ended December 31, 2008 was paid on February 17, 2009 . Genesis Biotech and Genesis Management are affiliated with Genesis Investment Funds Limited (which was already the majority shareholder of Cogenco), and as a result of these transactions Genesis Investment Funds Limited directly or indirectly owns 97% of Cogenco’s outstanding shares of common stock.

 
     
 
 
 
 
 

9

ITEM 2.      MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The statements contained in this Report on Form 10-Q that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding our expectations, hopes, intentions or strategies regarding the future. Forward looking statements include: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending, and our product development and marketing strategies; statements regarding future capital expenditures and financing requirements; and similar forward looking statements. All forward-looking statements included in this document are based on information available to us on the date hereof, and we undertake no obligation to update any such forward-looking statements. It is important to note that our actual results could differ materially from those in such forward-looking statements.

Material Changes in Financial Condition

Except for a series of equity financings in 2005, 2006, and 2007 and the activities related to DMI (described in our annual report on Form 10-KSB, as amended, for the year ended March 31, 2008), Cogenco has not engaged in any business operations for more than the past five years. Cogenco has not received any revenues from operations for more than the past ten years. We have not had an equity interest in DMI since March 2008 and no longer expect to pursue any further business opportunities with DMI.

Since the time Cogenco ceased active business operations in 1988, at times we have been seeking potential business opportunities. As a result of our lack of liquidity, lack of assets and lack of business operations, we believe the current general weakness and volatility in the capital markets are likely to make it especially difficult for us to obtain debt or equity financing. However, if we identify an appropriate business opportunity either domestically or abroad we will attempt to pursue that opportunity. There can be no assurance that if we identify an appropriate business opportunity that we will have, or be able to obtain, the financial resources to pursue that opportunity.

On December 31, 2008, we had working capital deficit of $(85,900) which represents an increase of $2,122 from our working capital deficit of $(83,778) on March 31, 2008. The increase to our working capital deficit is primarily a result of the receipt of the quarterly note payment from Genesis Capital Management Limited (“Genesis”) net of our continuing operating losses and our use of cash assets to pay our general administrative obligations.

On March 31, 2008 our assets included a certificate of deposit in the amount of $84,727 which was then pledged as collateral on a letter of credit in the amount of $70,000 securing the lease for our office space. On May 28, 2008 the certificate of deposit then in the amount of $85,436 was redeemed. Cash proceeds of $37,560 from the redemption were used to prepay our office rent through December 2008 and release Cogenco from the $70,000 letter of credit securing the lease. However, because we only prepaid the rent through December 31, 2008 as of December 31, 2008 we did not have any assets that are classified as prepaid expenses.

The primary reasons that our cash assets increased from March 31, 2008 to December 31, 2008 were:

     § The remaining funds realized from the redemption of the certificate of deposit after the prepayment of our rent and the release of the letter of credit as described above; and

10


       § Our receipt of $25,000 on both June 26, 2008 and November 5, 2008 pursuant to a promissory note due to us from Genesis (an affiliate of our 97% shareholder).

The note issued from Genesis obligates Genesis to pay us $25,000 per quarter with the final payment due on December 31, 2010, with total principal and interest payments totaling $275,000. Although it did not make the payment by September 30, 2008 as required under the note, Genesis made the second payment of $25,000 on November 5, 2008. Genesis made the third $25,000 payment due under the note on February 17, 2009. As of December 31, 2008 $112,649 of the note is classified as current (versus $85,803 as of March 31, 2008) as we expect this amount to be paid to us by December 31, 2009. Absent our acquisition of additional assets or funding, as installment payments are made under the note our total assets will likely decrease as we expect to use the funds to pay our on-going general obligations.

Our largest current liability is the accrued salary to our president, amounting to $241,750 at December 31, 2008. Effective March 31, 2008 our president orally agreed to suspend any further accrual of the salary due to him until we are adequately financed. Accordingly, the line item for our liability for “accrued salary – officer” on our balance did not change from March 31, 2008 to December 31, 2008. Our other significant current liability is a $7,366 accounts payable owed to our president and fees accrued to his father, a former Cogenco director. In both cases, our president and his father have orally agreed to defer collecting any salary or fee amounts owed to them until Cogenco is, in the Board’s opinion, adequately financed. Although Cogenco has a working capital deficit, management believes that as a result of the deferrals and agreements of our president and his father, Cogenco will be able to continue to pay its obligations to third parties as they become due.

We have had significant cash flow difficulties. Except for a salary payment of $2,000 that was made in June 2007, we have deferred payment of related party salaries and fees. During recent fiscal years, we paid our operating expenses with funds raised from the issuance of common stock and the sale of marketable securities we held. We no longer hold any marketable securities and have not raised funds through the issuance of common stock since March 2007. Currently, we expect to use funds due to us under the promissory note due to us from Genesis to help pay our general corporate expenses, not including the amounts due to our president. If Genesis is unable to pay its obligations under the note as they become due it will likely have a significant negative effect on our ability to pay our general expenses and obligations. Given the current state of the financial markets, we cannot offer any assurance that we will be able to raise any additional funds if it should become necessary.

Material Changes in Results of Operations

We are not operating in any business at this time, although we are continuing to seek out business opportunities. Business opportunities require working capital to investigate and complete, and at the present time we do not have the necessary working capital and especially with the current market conditions we can offer no assurance that, if the need arises, we will be able to obtain financing on reasonable terms, if at all. We have not received any revenues from operations for more than the past ten years and, therefore, we anticipate that we will continue to incur losses.

During the nine months ended December 31, 2008, we had a net loss of $(71,307). This represents a $169,047 decrease from our net loss of $(240,354) for the nine months ended December 31, 2007. The net loss for the nine months ended December 31, 2008 was caused primarily by costs and expenses consisting of rent and storage of $48,590, general and administrative expenses of $26,578, and consulting and traveling expenses of $18,290, with minimal offsetting interest income of $12,100 and rental income of $24,805. Our loss for the nine months ended December 31, 2008 was significantly less than that realized during the comparable period in 2007 primarily as a result of our president agreeing to suspend the accrual of his salary on March 31, 2008 (whereas in the comparable period in 2007 we accrued $112,500 for his salary) and a decrease of $38,135 in legal costs ($52,302 during the nine months ended December 31, 2007 versus $14,167 for the nine months ended December 31, 2008).

11


Our net loss for the quarter ended December 31, 2008 was $(16,723) as compared to a loss of $(53,792) during the comparable period in 2007. This decrease in our net loss is the result of our overall decreased costs and expenses in the quarter ended December 31, 2008 as compared to the comparable period in 2007. As with the nine month period, our decreased costs during the quarter ended December 31, 2008 in large part resulted from our president’s agreement to suspend accrual of his salary (whereas in the quarter ended December 31, 2007 we accrued $37,500 for his salary).

For the nine months ended December 31, 2008, total stockholders’ equity decreased $71,307 to $10,682 as compared to $81,989 as of March 31, 2008. The decrease in stockholders’ equity is primarily the result of the continued operating losses experienced by the Company and the corresponding rise in our accumulated deficit.

Plan of Operations

Cogenco is not engaged in any business operations at the present time. Although at times we receive proposals for business opportunities from third parties and we may seek out business opportunities with others, we have not actively pursued any such business opportunity in more than the past two years except for the business transactions with DMI that were discussed in our annual report on Form 10-KSB for the year ended March 31, 2008. Our agreements with DMI have been terminated and we do not expect to pursue any further business opportunities with or through DMI. To identify and pursue business opportunities will likely require that we obtain a significant amount of additional capital, either directly or as a condition of a business combination. We will continue to consider and review business opportunities in a range of industries as we become aware of any opportunities that we believe are appropriate.

We likely will not be able to pursue any business opportunity without a substantial amount of additional funding provided from third parties. As noted above, as a result of current general market conditions, it is likely that additional debt or equity financing will be more difficult for us to obtain until general market conditions improve. Accordingly, we cannot offer any assurance that we will be able to obtain the funds necessary to invest in other business opportunities. Going forward, we plan to use the payments due us under the note issued by Genesis to help pay for our routine legal and administrative expenses. As noted above, if Genesis is unable to make such payments as they become due it will have a significant negative effect on our ability to make such payments and remain a going concern. The next $25,000 payment under the note is due on or before March 31, 2009.

Off Balance Sheet Arrangements

We have no off balance sheet arrangements and thus no disclosure is required. Cogenco has an obligation to pay rent to an unaffiliated party under an office lease through December 2008 at the rate of $5,350 per month. This obligation is not reflected on Cogenco’s balance sheet, although our rent expense is recognized on our Statement of Operations.

12


ITEM 3.       QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4T.      CONTROLS AND PROCEDURES

Our management, with the participation of our principal executive officer and our principal financial officer has evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of December 31, 2008 (the end of the period covered by this report). Based on that evaluation, our principal executive officer and our principal financial officer have concluded that because of the material weakness identified in our internal control over financial reporting described in our annual report for the year ended March 31, 2008 on Form 10-KSB/A-1, that, our disclosure controls and procedures were not effective as of December 31, 2008. Due to a lack of financial resources, we are not able to, and do not intend to, immediately take any action to remediate the material weaknesses identified.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2008, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1.      LEGAL PROCEEDINGS.

Not applicable.

ITEM 1A.      RISK FACTORS.

There have been no material changes to the information included in risk factors set forth in our Annual Report on Form 10-KSB/A-1 for the year ended March 31, 2008 except the risks related to the nation’s general economic conditions.

ITEM 2.      UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Not applicable.

ITEM 3.      DEFAULTS UPON SENIOR SECURITIES.

Not applicable.

13


ITEM 4.      SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

Not applicable.

ITEM 5.      OTHER INFORMATION.

During the quarter ended December 31, 2008 there were no material changes to the procedures by which security holders may recommend nominees to the Company’s board of directors. Shareholders may recommend nominees to the board of directors by addressing correspondence to the President.

ITEM 6.      EXHIBITS

A Exhibits
    
31.      Certification pursuant to Rule 13a-14(a).
 
32.      Certification pursuant to 18 U.S.C. §1350.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:      February 17, 2009    /s/     David W. Brenman 
    David W. Brenman, President 
    Principal Executive Officer, Principal Accounting Officer,     
    Principal Financial Officer and Director 

14



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
12/31/1010-Q
12/31/0910-Q
3/31/0910-K,  NT 10-K
Filed on:2/17/09
2/12/09
For Period End:12/31/08
11/5/08
10/1/08
9/30/0810-Q
6/26/08
5/28/08
3/31/0810KSB,  10KSB/A
3/7/088-K
12/31/0710QSB
6/22/07
3/31/0710KSB,  NT 10-K
1/1/07
8/31/06
8/15/06
9/30/0510QSB,  NT 10-Q
 List all Filings 
Top
Filing Submission 0001000096-09-000066   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Feb. 22, 8:48:16.1am ET